🚨 Windtree Therapeutics announces raising $520 million to buy $BNB for its treasury.
This announcement follows a planned $200 million purchase of $BNB and a partnership with Kraken exchange for custody.
"Pending shareholder approval, the ability to obtain additional funds to buy more BNB is critical to our strategy"
- Jed Latkin, CEO of Windtree.
